| | 82419-36-1 Basic information More.. |
| Product Name: | Ofloxacin | | Synonyms: | (+/-)-9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid;AKOS NCG1-0050;OFLOXACIN;(-)-(s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;TARIVID;(+/-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid;OFLOXACIN USP 24 | | CAS: | 82419-36-1 | | MF: | C18H20FN3O4 | | MW: | 361.37 | | EINECS: | 680-263-1 | | Mol File: | 82419-36-1.mol |  |
Use
Ofloxacin is a fluoroquinolone antibiotic present as a racemic mixture. Levofloxacin, S-isomer of ofloxacin, shows a broad spectrum of antibacterial activity against both gram-positive and gram-negative bacteria. The antibacterial activity of levofloxacin is 8–128 times greater than that of the corresponding R-isomer. A novel esterase of type B1 carboxylesterase/lipase family from a marine isolate Y. lipolytica CL180 was used to resolve a racemic mixture of ofloxacin ester. This esterase showed an enantioselectivity toward R, S-ofloxacin ester, and levofloxacin was produced with an enantiomeric excess of 52 % (Kim et al. 2007).
- Ofloxacin
-
- US $0.00 / kg
- 2024-04-11
- CAS:82419-36-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
- Ofloxacin
-
- US $0.00-0.00 / mg
- 2024-04-10
- CAS:82419-36-1
- Min. Order: 10mg
- Purity: 90%+
- Supply Ability: 10g
- Ofloxacin
-
- US $0.00 / KG
- 2024-03-16
- CAS:82419-36-1
- Min. Order: 100g
- Purity: 98%+
- Supply Ability: 100kg
|
|
82419-36-1
Recommend Suppliers |
|